Trial NCT03540160

View at ClinicalTrials.gov 
Org. Study IDs: MTI-107
Secondary IDs: 2017-004211-40

Last trial update was posted on 2021-05-20

MeSH Interventions

Serlopitant

MeSH Conditions

Dermatitis Prurigo Pruritus Psoriasis

Other Conditions

Atopic Dermatitis Prurigo Nodularis

Stopping Reasons

No longer pursuing development of serlopitant

Limitations And Caveats

Due to a corporate decision to no longer pursue an indication of treatment for pruritus, and further to terminate the development program for serlopitant, the study was terminated prematurely.

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID